US states reopen as New York tests heartburn drug on coronavirus patients

An FDNY paramedic in the Bronx borough of New York
AP
Michael Howie27 April 2020

A swathe of US states were set to reopen businesses this week following mandatory lockdowns that have thrown nearly one in six American workers out of jobs.

Colorado, Mississippi, Minnesota, Montana and Tennessee are among the states preparing to ease restrictions, despite disquiet among health experts about the risk of fuelling a second wave of infections.

It comes as the number of confirmed US cases was expected to reach one million today, with more than 55,000 fatalities.

Meanwhile, in New York, a common heartburn drug is being tested on Covid-19 patients following signs that it may have helped survivors of the virus in China.

Nearly 200 patients have enrolled in the clinical trial of famotidine and doctors are hoping to produce preliminary results within weeks.

New York's Coronavirus outbreak - In pictures

1/26

The trial is being carried out by Feinstein Institutes for Medical Research, the research arm of Northwell Health, which runs 23 hospitals in and around New York.

The idea came after early studies in China appeared to show that patients taking the drug fared better than those who were not.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in